United States - Healthcare - FDA Finalizes Rule And Sets Course To Phase In Oversight Of Laboratory Developed Tests

On May 6, 2024, following more than a decade of discourse with interested stakeholders on potential approaches to regulation of laboratory developed tests (LDTs)...

Related Keywords

,Public Health Surveillance ,Diagnostics Pilot Program ,Department Of Defense Do ,Veterans Health ,Devices For Immediate Public Health Response ,Enforcement Discretion ,Clinical Laboratory Improvement Amendments ,Changes Were Made ,Federal Food ,Cosmetic Act ,Federal Register ,Final Phaseout ,Remain Under Active ,Blood Donor Screening ,Enforcement Policies ,Certain In Vitro Diagnostic ,Immediate Public Health Response ,Drug Products Used ,Certain In Vitro ,Generally Remaining ,Under Full Enforcement ,Leukocyte Antigen ,Law Enforcement ,Public Health ,Under Partial Enforcement Discretion ,Discretion Limited ,York State Department ,Health Clinical Laboratory Evaluation ,Currently Marketed ,Same Healthcare ,Unmet Need ,